Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart

Cardiovascular Research

Volumn 36, Issue 1, 1997, Pages 60-66

  Brunner, Friedrich ^a   Leonhard, Bernhard ^a   Kukovetz, Walter R ^a   Mayer, Bernd ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Endothelin; Ischaemic cell death; Nitric oxide; Nitric oxide donor; Rat; Reperfusion injury; Vascular endothelium

Indexed keywords

ARGININE; ENDOTHELIN; NITRIC OXIDE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION TEST; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ANIMALS; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC GMP; ENDOTHELIN-1; L-LACTATE DEHYDROGENASE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; OLIGOPEPTIDES; PENICILLAMINE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; S-NITROSO-N-ACETYLPENICILLAMINE; VASODILATOR AGENTS;

EID: 0030697837     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00138-7     Document Type: Article

References (39)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3:2007-2018.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
3. Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
6. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993; 33:71-90.
7. Seccombe JF, Schaff HV. Coronary artery endothelial function after myocardial ischemia and reperfusion. Ann Thor Surg 1995; 60:778-788.
8. Fukuda H, Sawa Y, Kadoba K, et al. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 1995; 92 (suppl. II): II-413-II-416.
9. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischemic heart. Cardiovasc Res 1995; 30:593-601.
10. Pabla R, Buda AJ, Flynn DM, Salzberg DB, Lefer DJ. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 1995; 269:H1113-H1121.
11. Lefer AM. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thor Surg 1995; 60:847-851.
12. Weyrich AS, Ma S-I, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86:279-288.
13. Nakanishi K, Vinten-Johansen J, Lefer DJ, et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 1992; 263:H1650-H1658.
14. Sato H, Zhao Z-Q, McGee DS, et al. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995; 110:302-314.
15. Matheis G, Sherman MP, Buckberg GD, et al. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262:H616-H620.
16. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 1995; 30:432-439.
17. Hasdai D, Kornowski R, Battler A. Endothelin and myocardial ischemia. Cardiovasc Drugs Ther 1994; 8:589-599.
18. Grover G, Dzwonczyk S, Parham C. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993; 27:1613-1618.
19. Wang Q-D, Li X-S, Lundberg JM, Pernow J. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc Res 1995; 29:805-812.
20. B receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol 1995; 114:949-954.
21. Grover GJ, Sleph PG, Fox M, Trippodo NC. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther 1992; 263:1074-1082.
22. B antagonist. Br J Pharmacol 1994; 113:869-876.
23. 2+ modulation during postischemic reperfusion in rat heart. Am J Physiol 1995; 268:H100-H111.
24. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun 1989; 164:678-685.
25. 2+. Biochem Pharmacol 1995; 49:1785-1791.
26. Brunner F. Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion. J Mol Cell Cardiol 1995; 27:1953-1963.
27. Cody WL, Doherty AM, He JX, et al. Design of a functional hexapeptide antagonist of endothelin. J Med Chem 1992; 35:3301-3303.
28. Knecht R, Chang J-Y. Liquid Chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Analyt Chem 1986; 58:2375-2379.
29. Schmidt K, Mayer B, Kukovetz WR. Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells. Eur J Pharmacol 1989; 170:157-166.
30. Maragos CM, Morley D, Wink DA, et al. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 1991; 34:3242-3247.
31. Hagar JM. Endogenous endothelin-1 impairs endothelium-dependent relaxation after myocardial ischemia and reperfusion. Am J Physiol 1994; 267:H1833-H1841.
32. 2+ from a caffeine- and ryanodine-insensitive intracellular pool in rat atrial cells. J Biol Chem 1990; 265:6782-6787.
33. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res 1994; 75:369-378.
34. Kelly RA, Eid H, Krämer BK. et al. Endothelin enhances the contractile responsivness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest 1990; 86:1164-1171.
35. Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub MH. L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res 1995; 30:200-204.
36. Baydoun RA, Emery PW, Pearson JD, Mann GE. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem Biophys Res Commun 1990; 173:940-948.
37. Griffith OW, Stuehr DJ, Nitric oxide synthases: Properties and catalytic mechanism. Ann Rev Physiol 1995; 57:707-736.
38. Mayer B. Biochemistry and molecular pharmacology of nitric oxide synthases. In: Vincent SR, ed. Nitric Oxide in the Nervous System. New York: Academic Press, 1995: 21-42.
39. Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett 1995; 376:262-266.